Evidence map›Paper›PMID 31612285›Full record

ReviewWorld journal of microbiology & biotechnology2019

Antibacterial activities of transient metals nanoparticles and membranous mechanisms of action.

Lilit Gabrielyan, Armen Trchounian

Abstract readReview
PubMed Publisher
In one paragraph

Review in World journal of microbiology & biotechnology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Emerging Resistance and Virulence Patterns inAntibiotics (Basel, Switzerland) · 2025
    Article
  5. Article
  6. Nanoarchitectonics for synergistic activity of multimetallic nanohybrids as a possible approach for antimicrobial resistance (AMR).Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry · 2024
    Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Silver Nanoparticles ofPlants (Basel, Switzerland) · 2023
    Article
  12. Article
  13. Antibiotics (Basel, Switzerland) · 2022
    Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Lilit GabrielyanDepartment of Medical Biochemistry and Biotechnology, Russian-Armenian University, 123 H. Emin Str., 0051, Yerevan, Armenia.
Armen TrchounianDepartment of Medical Biochemistry and Biotechnology, Russian-Armenian University, 123 H. Emin Str., 0051, Yerevan, Armenia. Trchounian@ysu.am.ORCID http://orcid.org/0000-0002-0901-4893
Russian-Armenian University · AM

Funding

Russian-Armenian University, Yerevan (AM) Basic support
6 · The paper itself

Abstract

Various transient metal and metal oxide nanoparticles (NPs) have shown pronounced biological activity, including antibacterial action against different Gram-negative and Gram-positive bacteria including pathogens and drug-resistant ones. Thus, NPs can be applied in nanotechnology for controlling bacterial growth as well as in biomedicine for the treatment of various diseases. However, the mechanisms of these effects are not clear yet. This review is focused on the antibacterial effects of transient metal NPs, especially iron oxide (Fe

Indexed as

MembranesAnti-Bacterial AgentsBacteriaDrug Resistance, BacterialEscherichia coliFerric CompoundsMetal NanoparticlesNanotechnologyReactive Oxygen SpeciesSilverAnti-Bacterial AgentsFerric Compoundsferric oxideReactive Oxygen SpeciesSilverAntibacterial actionAntibiotic-resistanceATPase activityBacteriaH2 production by hydrogenasesH+-fluxesMembranous mechanismsMetal nanoparticlesRedox potential

Identifiers

PMID31612285
OpenAlexW2980534963

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.